文献速递先天性心脏病外科心外重症与机械循环支持

瞄准月亮:猪心脏异种移植的基因组编辑

Shooting for the moon: Genome editing for pig heart xenotransplantation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-05-07

本文评述基因组编辑技术如何革新心脏异种移植,使生物工程猪心脏移植入人成为可能。基因编辑猪心脏可能最适合免疫系统未成熟的新生儿和婴儿,也可作为人工心脏移植的桥接,避免耐久性心室辅助装置的血栓栓塞风险,并有望减少免疫抑制需求。本期杂志中Cooper博士团队概述了基因组编辑生物工程心脏的现状并讨论了临床应用前景。

要点

  • 基因编辑猪心脏可能为新生儿和婴儿提供避免外源性免疫抑制的器官来源。
  • 生物工程猪心脏或可作为儿童心脏移植的桥接,避免耐久性心室辅助装置的血栓栓塞风险。
  • 以猪为宿主的生物工程心脏可能成为不引发人免疫反应且减少免疫抑制需求的新供体来源。

核心结论

  • 基因编辑猪心脏最终可能提供安全有效且无需外源性免疫抑制即可免受人类免疫反应的器官。
  • 基因组编辑技术已革新心脏异种移植,使生物工程猪心脏移植入人成为可能。
  • 基因编辑猪心脏似乎最适合免疫系统未成熟的新生儿和婴儿,也可作为人心脏移植的桥接。

研究设计与样本

  • 本文为综述/评论文章,评述基因组编辑心脏异种移植的现状与临床应用前景。
  • 本期杂志中由Cooper博士领导的专家团队(其个人工作跨越50余年心脏移植研究)概述了基因组编辑生物工程心脏的当前状态。

主要发现

  • 野生型猪心脏移植入狒狒后发生超急性排斥反应。
  • 基因组编辑技术已使生物工程猪心脏移植入人成为可能,首次临床应用源于大量研究。
  • 上世纪临床心脏异种移植的早期尝试为使用生物工程猪心脏的现代异种移植铺平了道路。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gene-edited pigs could eventually provide organs that are safely and effectively protected from the human immune response without exogenous immunosuppression. [Image: see text] Hyperacute rejection of a wild-type pig heart after transplantation into a baboon. Genome editing technology has revolutionized heart xenotransplantation and made transplantation of bioengineered pig hearts into humans a possibility. This first clinical application resulted from a tremendous amount of research. Dramatic early attempts of clinical cardiac xenotransplantation during the last century paved the way to modern xenotransplantation using bioengineered pig hearts. It appears that such genome-edited hearts will be most suitable for neonates and infants because of their immature immune system. The bioengineered pig heart may also be used as a bridge to human heart transplantation, avoiding the risk of thromboembolic events of durable ventricular assist devises in these young children. It is also intriguing to think that bioengineered hearts using pigs as a host may result in a new source of donor hearts that would not evoke the human immune response and minimize, if not eliminate, the need for immunosuppression. It this issue of the Journal, a group of experts led by Dr Cooper, whose personal work spans over 50 years of heart transplantation research, outline the current state of the genome editing of bioengineered hearts and discuss the prospects of clinical application.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Cooper DKC, Raza SS, Chaban R, et al. Shooting for the moon: Genome editing for pig heart xenotransplantation. J Thorac Cardiovasc Surg. 2022. PMID: 35659123. doi:10.1016/j.jtcvs.2022.04.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。